Minimalist mRNAs: A fast track to cancer vaccines

The manuscript by Esprit et al. analyzes the relevance of different elements of in vitro-transcribed (IVT) mRNAs in order to simplify their use as cancer vaccines.1 The authors concluded that some elements generally considered stabilizing —such as 5′ and 3′ untranslated regions (UTRs) and the poly(A) tail— could be dispensable for mRNAs used to express small antigens by antigen-presenting cells (APCs). In addition, they developed a simple method for generating synthetic DNA templates (SDTs), accelerating the production of small mRNAs and allowing rapid high-throughput screening of cancer neoepitopes.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2025-08-18
DOI
https://doi.org/10.1016/j.omtn.2025.102669
Citations
2
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
1.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Minimalist mRNAs: A fast track to cancer vaccines

Cristian Smerdou, Noelia Silva-Pilipich, Ángela Covo-Vergara, Uxue Beloki et al.
2 citations
Molecular Therapy — Nucleic Acids
Immunotherapy and Immune Responses
1.59
article

Minimalist mRNAs: A fast track to cancer vaccines

Cristian Smerdou, Noelia Silva-Pilipich, Ángela Covo-Vergara, Uxue Beloki, Laura Salaberry
article en
2 citations

Abstract

The manuscript by Esprit et al. analyzes the relevance of different elements of in vitro-transcribed (IVT) mRNAs in order to simplify their use as cancer vaccines.1 The authors concluded that some elements generally considered stabilizing —such as 5′ and 3′ untranslated regions (UTRs) and the poly(A) tail— could be dispensable for mRNAs used to express small antigens by antigen-presenting cells (APCs). In addition, they developed a simple method for generating synthetic DNA templates (SDTs), accelerating the production of small mRNAs and allowing rapid high-throughput screening of cancer neoepitopes.

Molecular Therapy — Nucleic AcidsVol. 36(3)
SOM Biotech (Spain) (ES), Navarre Institute of Health Research (ES), Universidad de Navarra (ES)
European Commission, Gobierno de Navarra, Instituto de Salud Carlos III
Openalex Percentile: Top 15%
Immunotherapy and Immune Responses
1.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Minimalist mRNAs: A fast track to cancer vaccines — Cristian Smerdou, Noelia Silva-Pilipich, et al. · Molecular Therapy — Nucleic Acids (2025) | TGRS Research Map | TGRS